Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acadia

19.22
-0.0400-0.21%
Post-market: 19.220.00000.00%16:04 EDT
Volume:1.22M
Turnover:23.61M
Market Cap:2.52B
PE:116.09
High:19.48
Open:19.19
Low:19.13
Close:19.26
Loading ...

Acadia Realty Trust EVP and CIO Reginald Livingston Reports Disposal of Common Shares

Reuters
·
14 Jun

Acadia court ruling supports Nuplazid exclusivity into 2030, says Mizuho

TIPRANKS
·
11 Jun

Acadia Pharmaceuticals Wins Patent Case for NUPLAZID

TIPRANKS
·
11 Jun

Acadia Realty Trust to Participate in NAREIT's REITweek®: 2025 Investor Conference

Reuters
·
31 May

Acadia Pharmaceuticals Holds 2025 Annual Stockholder Meeting

TIPRANKS
·
30 May

Acadia Realty (AKR) Gets a Buy from Truist Financial

TIPRANKS
·
28 May

Deutsche upgrades Acadia to Buy on new ‘valuation floor’

TIPRANKS
·
21 May

Acadia Pharmaceuticals upgraded to Buy from Hold at Deutsche Bank

TIPRANKS
·
21 May

Acadia Pharmaceuticals price target raised to $28 from $24 at BMO Capital

TIPRANKS
·
19 May

Acadia Pharmaceuticals price target raised to $23 from $20 at Mizuho

TIPRANKS
·
19 May

Acadia Pharmaceuticals price target raised to $31 from $28 at Baird

TIPRANKS
·
19 May

Acadia Pharmaceuticals Wins Patent Case Involving Parkinson's Disease Treatment

Dow Jones
·
17 May

Acadia Wins Nuplazid Patent Case in Delaware Court; Shares Surge

MT Newswires Live
·
17 May

Acadia court ruling alleviates overhang for Nuplazid, says RBC Capital

TIPRANKS
·
17 May

Acadia confirms court ruling in favor of Nuplazid formulation patent

TIPRANKS
·
17 May

Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer

TIPRANKS
·
17 May

Acadia Nuplazid patent ruling removes ‘key overhang,’ says BMO Capital

TIPRANKS
·
17 May

Acadia Pharmaceuticals price target raised to $30 from $27 at Needham

TIPRANKS
·
17 May

Acadia Pharmaceuticals files to sell 43.58M shares of common stock for holders

TIPRANKS
·
10 May

Press Release: Acadia Realty Trust Announces $0.20 Per Share Quarterly Dividend

Dow Jones
·
08 May